Keywords: Nitto Denko, Avecia Biotech, DNA and RNA-based therapeutics, Contract manufacturing, Nucleic acid drugs

Japan’s Nitto Denko acquires Avecia Biotechnology

Article | 07 February 2011

Japan’s leading diversified materials manufacturer, Nitto Denko Corp (TYO: 6988), last week announced that it has acquired privately-owned Avecia ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in